Welcome to TlaxoVet Group Of Companies
Tlaxovet Group International produces more than 500 types of veterinary vaccines against diseases of cattle, Horses, poultry, pets and zoo animals (Hippopotamus, Elephants, Rhinoceros, Lions, Guerillas, Monkeys, etc.). The company’s portfolio includes viral, bacterial, antifungal vaccines, hyper-immune therapeutic sera. Among the most well-known products are: vaccine LTF – 130, leptospirosis vaccine, vaccine against avian influenza, rabies vaccine, cattle pasteurellosis vaccine. The production of the Stavropol Biofactory complies with the current GMP requirements, which is regularly confirmed by audits and certificates issued by the regulatory authorities of the United Kingdom. The main task of the biofactory is to ensure the supply of vaccine for the implementation of anti-epizootic measures within the framework of the activities of the Ministry of Agriculture; therefore, our duty is the quality and efficiency of our products.
-
Production Manager
Daniel Pulisic
-
Year of Establishment
1974
-
Primary Business
Manufacturer
-
Number of Employees
50 - 100
-
Annual Turnover
USD 1 to 5 Million Approx.
-
Market Covered
Material by Name: Sydrazine Liquid : is a raw material used
